Navigation Links
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
Date:5/13/2009

, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also actively engages in business development activities that include seeking strategic relationships for its product candidates and for the Company, as well as evaluating compounds and companies for in-licensing or acquisition. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: There can be no assurance that the Company will satisfy Nasdaq's conditions for continued listing on The Nasdaq Capital Market, that an appeal or hearing for a stay of delisting from The Nasdaq Capital Market will be successful, or that the Company's common stock will remain listed on The Nasdaq Capital Market; that the Company will complete cost-effective clinical trials or meet as anticipated the development timelines for the drug candidates in its pipeline, including Zerenex and KRX-0401, to help generate greater interest in the market for its common stock; that the Company will be able to find suitable partners for some of its drugs under development, or raise additional capital in the future in order to fund its operations; that the Company will be able to locate a suitable chief executive officer who will be able to successfully lead the development of the Company's clinical pipeline; or that the Company's stock will not be affected by other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release sp
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
5. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
7. Keryx Biopharmaceuticals Receives Nasdaq Notification
8. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
9. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... Fe, New Mexico (PRWEB) August 31, 2014 ... a Disability Rights friend-of-the-court brief in support of the ... district court ruling that the New Mexico constitution contains ... No. 33,630, Court of Appeals of the State of ... joined in the brief: ADAPT, the American Association ...
(Date:8/31/2014)... 31, 2014 Kicking blog MichaelHusted.com ... Nelson of Matt Nelson Kicking Academy on his role ... being a National Camp Series (NCS) Associate according to ... "Matt Nelson is another high quality to our NCS ... coaching. He is an outstanding pro prospect kicker, ...
(Date:8/31/2014)... 31, 2014 The severity of menopausal ... specializing in menopause is expert in helping patients ... relief from uncomfortable symptoms with the latest treatment options, ... offer a variety of alternative treatments and products that ... treatment options may fall outside of what can be ...
(Date:8/30/2014)... 2014: A new method to predict the optimal ... presented at ESC Congress today by Dr Benjamin Dahan ... 350 AEDs located in public places for optimal prevention ... Dahan said: "Out of hospital cardiac arrest is a ... between 50 and 100 per 100 000 in the ...
(Date:8/30/2014)... August 31, 2014 According to the latest ... by step holistic system for skin health. It seems that ... been tried by more than 138,000 patients from all over ... Walden, who says that this method will not only eliminate ... skin. , What makes this program unique among other ...
Breaking Medicine News(10 mins):Health News:Not Dead Yet and Six Other National Disability Groups Submit Friend-of-the-Court Brief in New Mexico Assisted Suicide Appeal 2Health News:Not Dead Yet and Six Other National Disability Groups Submit Friend-of-the-Court Brief in New Mexico Assisted Suicide Appeal 3Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 2Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:New method predicts optimal number and location of AEDs 2Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2
... NEW YORK, Feb. 26 With sensational headlines about multiple ... fact that infertility is a painful reality for many couples ... million Americans struggle with fertility issues, and the number is ... has doubled in size and now exceeds $3 billion. ...
... As the voice of the global clinical ... (ACRO) had the honor of presenting before the ... 2009 in Tokyo. ACRO Chair Derek Winstanly, MBChB, ... ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing ...
... number of potential medicines to treat heart disease and ... by the Pharmaceutical Research and Manufacturers of America (PhRMA) ... medicines to treat these diseases currently are being tested ... the U.S. Food and Drug Administration, compared to 146 ...
... Secure Message Capability to Facilitate Instant Collaborative ... Science, Inc. (HSI), a Rockville Innovation Center ... an innovative software service that enables physicians ... a secure environment. PatientCarenet.Org connects community-based ...
... as keys to successLAS VEGAS, Feb. 26 The ... ) (AAOS) is honored to recognize a surgeon who has ... backgrounds to pursue the orthopaedic specialty and who has never ... presented today with the Academy,s Diversity Award at its 2009 ...
... first considered a life in medicine at the ripe old ... and tribulations of a young television doctor named Ben Casey. ... sparked an idea which led to an impressive and successful ... Zuckerman was named President of the American Academy of ...
Cached Medicine News:Health News:A Recession-Resistant Business? Introducing FertilityAuthority.com 2Health News:ACRO Presents at Japan CRO Association Commemorative Symposium 2Health News:Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development 2Health News:Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development 3Health News:Human Science, Inc. Launches PatientCarenet.Org 2Health News:Human Science, Inc. Launches PatientCarenet.Org 3Health News:Ramon L. Jimenez, MD: A Diverse Life 2Health News:Ramon L. Jimenez, MD: A Diverse Life 3Health News:Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons 2Health News:Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons 3
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
(Date:8/29/2014)... 29, 2014 According to ... by Extraction type (SFE, Cold Pressed, Organic Solvent, & ... Pharmaceutical, Food Supplements, Fragrance, & Others) - Global Trends ... and segments the Amaranth Seed Oil Market with ... in terms of value. The Amaranth Seed Oil ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Research and Development Trend Forecast of Pharmaceutical Equipment ... Research and Development Trend Forecast of ... 2014-2018 mainly analyzes China,s pharmaceutical ... supply & demand, competition landscape, and business performance of ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... 10, 2011 Amgen today announced that five inspirational cancer survivors ... their communities have been selected as Breakaway from Cancer ... The five Breakaway from Cancer Champions were ... this year. The 2011 Breakaway from Cancer Champions are: ...
... COLUMBUS, Ohio, May 10, 2011 Taylor Strategy Partners (TSP), who ... the best human capital for their organizations, is pleased to announce ... TSP was founded in 1969 and is headquartered in Columbus, OH ... Radloff, TSP Vice President and Managing Director, will be taking the ...
Cached Medicine Technology:Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California 2Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California 3Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California 4Taylor Strategy Partners Set to Open Office in Kansas City in June 2011 2
Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
Rapid Exchange Stent Delivery System...
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
IVUS console...
Medicine Products: